Bridging the Divide: Building Toward Earlier, Smarter, and More Connected Cancer Care
Disclaimer: Revelation Partners is invested in Carrum Health, Bristol Hospice, Genome Medical, and Metabolon. Fragmented, Costly, and Complex: The State of U.S. Cancer Care Over the past century, we have made remarkable strides in the fight against cancer—from the advent of chemotherapy in the 1940s to today’s targeted, immune, and cell-based therapies that have expanded […]
Revelation-Backed Omada Health Jumps After $150 Million IPO
Omada Health Inc. shares climbed 21% in their trading debut after the digital health-care company raised $150 million in its initial public offering. The stock opened at $23 on Friday in New York, higher than its IPO price of $19 per share. The San Francisco-based company sold 7.9 million shares at $19 each after offering them at $18 to $20 […]
Fuze Health Launches to Transform Patient Experiences and Enable Personalized Care in a Changing Healthcare Environment
Fuze Health, a technology-powered healthcare solutions company committed to transforming patient experiences and advancing personalized care, launched today. The company is focused on enabling healthcare partners – including care providers, employers, health plans and life sciences companies – to excel in an outcomes-focused system and empowering patients to more comprehensively manage their health at home. […]
Beyond the Drug: Investment Opportunities in the Growing GLP-1 Market
In this white paper, we cover:
Venture Secondary Summit 2025: Key takeaways
The inaugural Venture Secondary Summit, held in California from April 1–2, convened leadingvoices from across the venture capital secondaries ecosystem. The two-day event featured arange of discussions—from market sizing and structural innovation, to growth expectations anddifferentiation strategies—drawing participation from firms including Jefferies, Kline Hill,Lazard, Campbell Lutyens, StepStone Group, Goldman Sachs, and more. To glean further […]
Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
Click Therapeutics, Inc., (“Click”) a leader in prescription medical treatments as both prescription digital therapeutics and software-enhanced drug™ therapies, has obtained FDA marketing authorization for the first prescription digital therapeutic for the preventive treatment of episodic migraine. FDA granted the De Novo Classification Request for the company’s prescription digital therapeutic, CT-132, for the preventive treatment […]
Summit Spine Expands with a Unique Physician-Centric Model in Interventional Spine Care
Summit Spine & Joint Centers (“Summit”), a leading minimally invasive spinal services platform, is revolutionizing the field with a distinctive structure that combines hospital affiliations, and Ambulatory Surgery Center (ASC) ownership opportunities for physicians. This innovative model has been the driving force behind the company’s sustained growth over the past ten years. Summit completed a recapitalization with […]
Omada Partners with CVS Caremark on Weight Management Program
Omada Health is joining forces with CVS Health’s Caremark as part of the pharmacy benefit manager’s weight management program. This marks Omada’s second partnership with a major PBM, following its team-up with Cigna’s Express Scripts within its EncircleRx initiative. Omada offers an enhanced care track program for GLP-1 drugs that seeks to make it easier […]
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
In the latest investment in the immunology space, Sanofi has agreed to a $600 million upfront payment to buy Dren Bio’s investigational bispecific antibody DR-0201 in a deal announced Thursday. The asset is a targeted cell engager that binds to the CD20 protein on B cells, tagging them for destruction. In early clinical studies, DR-0201 has demonstrated the ability […]
Key Takeaways from HPE Miami 2025: A Cautious Yet Evolving Private Equity Landscape
The Revelation Partners team was in Miami March 5-6 for the HPE Miami Conference. The conference, which has become the “go-to” event for private equity sponsors (who can pass up a trip to Miami in March?), brought together thousands of attendees to discuss the current state of the market, emerging trends, and challenges facing the […]